Table 2

Key clinical characteristics of people with Parkinson’s disease in the full and purposive samples

MeasureFull samplePurposive sample
Disease duration (years)6.5 (8.3)*9.0 (9.5)*
MoCA22.9 (3.6)22.2 (3.3)
HADS11.0 (8.5)*9.6 (4.8)
LEDD640.5 (656.5)*691.5 (1027.3)*
  • Figures are mean (SD), unless when marked with * in which case they are median (IQR).

  • HADS, Hospital Anxiety and Depression Scale; LEDD, Levodopa Equivalent Daily Dose; MoCA, Montreal Cognitive Assessment.